PHARMING GRP SP. ADRS (PHG) — Working Capital to Net Assets Ratio

Latest as of December 2025: 66.3%

PHARMING GRP SP. ADRS (PHG) has a Working Capital to Net Assets ratio of 66.3% as of December 2025. Working capital of €183.68 Million (current assets of €299.47 Million minus current liabilities of €115.79 Million) is measured against net assets of €277.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PHG cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

66.3%
Working Capital / Net Assets

Working Capital

€183.68 Million
EUR

Current Assets

€299.47 Million
EUR

Current Liabilities

€115.79 Million
EUR

PHARMING GRP SP. ADRS Working Capital to Net Assets (2021–2025)

This chart shows how PHARMING GRP SP. ADRS's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 66.3%, reflecting working capital of €183.68 Million against net assets of €277.10 Million EUR. For the complete balance sheet picture, see PHARMING GRP SP. ADRS (PHG) total assets.

Annual Working Capital to Net Assets for PHARMING GRP SP. ADRS (2021–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PHG cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Year WC/NA Ratio Working Capital (EUR) Net Assets Current Assets Current Liabilities Change (pp)
2025 66.3% €183.68 Million €277.10 Million €299.47 Million €115.79 Million ▼ -26.3 pp
2024 92.6% €204.64 Million €221.06 Million €278.44 Million €73.80 Million ▼ -16.4 pp
2023 109.0% €238.37 Million €218.78 Million €316.34 Million €77.97 Million ▲ +2.5 pp
2022 106.4% €217.80 Million €204.64 Million €277.50 Million €59.70 Million ▲ +1.4 pp
2021 105.1% €202.67 Million €192.92 Million €249.44 Million €46.77 Million
pp = percentage points